CFG
PFE icon

Capstone Financial Group’s Pfizer PFE Stock Holding History

Capstone Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.17M Sell
33,942
-680
-2% -$23.8K 0.9% 36
2020
Q2 		$1.12M Buy
34,622
+2,917
+9% +$99.1K 0.92% 38
2020
Q1 		$982K Sell
31,705
-5,673
-15% -$193K 1.01% 34
2019
Q4 		$1.39M Buy
+37,378
New +$1.33M 1.34% 28

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capstone Financial Group's PFE Position: Q3 2020 in Review

Capstone Financial Group reduced its Pfizer (PFE) stake by 2% in Q3 2020, selling an estimated $23.8K and leaving 33,942 shares worth $1.17M. The position accounts for 0.9% of the portfolio, ranked #36.

Capstone Financial Group first reported a position in PFE in Q4 2019 and has held it in 4 quarters since. The position peaked at $1.39M in Q4 2019. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Capstone Financial Group held 33,942 shares of Pfizer worth $1.17M as of Q3 2020.
  • Capstone Financial Group sold 680 Pfizer shares in Q3 2020, an estimated $23.8K.
  • Pfizer made up 0.9% of Capstone Financial Group's portfolio in Q3 2020, its #36 holding.
  • Capstone Financial Group first reported a position in Pfizer in Q4 2019 and has held it in 4 quarters since.
  • Capstone Financial Group's Pfizer position peaked at $1.39M in Q4 2019.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Capstone Financial Group's 13F filing for Q3 2020, filed 9 Oct 2020.